作者: Texture 時間: 2025-3-22 00:03 作者: Cpr951 時間: 2025-3-22 01:03 作者: affect 時間: 2025-3-22 05:10
Pathophysiology of HCC,s process. Interaction of a variety of cell types in the tumor stroma with extracellular matrix components lead to the acquisition of an abnormal phenotype that promotes tumor formation. It has also been demonstrated that hypoxia enhances progression, and metastasis of HCC. Activation of epithelial-作者: 友好 時間: 2025-3-22 12:04 作者: FAZE 時間: 2025-3-22 13:44 作者: insurgent 時間: 2025-3-22 18:29 作者: Rebate 時間: 2025-3-22 23:21
Conclusions,llular processes and pathways. Thus, molecules such as Sorafenib and microRNAs, which can target multiple pathways simultaneously are necessary therapeutic tools for HCC. Lack of good molecular markers, effective early diagnosis, and an ideal animal model are also major hindrances to treat HCC. Ther作者: 觀點 時間: 2025-3-23 01:38
ion is the preferred systemic treatment for disseminated prostate cancer. Androgen action is exerted in target tissues via binding the androgen receptor (AR), a nuclear receptor transcription factor. ...Historically, the gene expression program mediated by the AR has been poorly understood. However,作者: commonsense 時間: 2025-3-23 05:46
Rajagopal N. Aravalli,Clifford J. Steerion is the preferred systemic treatment for disseminated prostate cancer. Androgen action is exerted in target tissues via binding the androgen receptor (AR), a nuclear receptor transcription factor. ...Historically, the gene expression program mediated by the AR has been poorly understood. However,作者: Externalize 時間: 2025-3-23 10:28 作者: 雀斑 時間: 2025-3-23 14:21 作者: 衰老 時間: 2025-3-23 18:40 作者: 織布機(jī) 時間: 2025-3-24 00:04
Rajagopal N. Aravalli,Clifford J. Steerontribute to the development and progression of prostate can.Androgens are critical regulators of prostate differentiation and function, as well as prostate cancer growth and survival. Therefore, androgen ablation is the preferred systemic treatment for disseminated prostate cancer. Androgen action 作者: 褪色 時間: 2025-3-24 04:17
Rajagopal N. Aravalli,Clifford J. Steerontribute to the development and progression of prostate can.Androgens are critical regulators of prostate differentiation and function, as well as prostate cancer growth and survival. Therefore, androgen ablation is the preferred systemic treatment for disseminated prostate cancer. Androgen action 作者: cluster 時間: 2025-3-24 08:12
Rajagopal N. Aravalli,Clifford J. Steerontribute to the development and progression of prostate can.Androgens are critical regulators of prostate differentiation and function, as well as prostate cancer growth and survival. Therefore, androgen ablation is the preferred systemic treatment for disseminated prostate cancer. Androgen action 作者: 權(quán)宜之計 時間: 2025-3-24 12:41 作者: contradict 時間: 2025-3-24 16:53
ion is the preferred systemic treatment for disseminated prostate cancer. Androgen action is exerted in target tissues via binding the androgen receptor (AR), a nuclear receptor transcription factor. ...Historically, the gene expression program mediated by the AR has been poorly understood. However,作者: 帶傷害 時間: 2025-3-24 22:40
Hepatocellular Carcinoma978-3-319-09414-4Series ISSN 2194-1173 Series E-ISSN 2194-1181 作者: 一加就噴出 時間: 2025-3-25 01:07
Rajagopal N. Aravalli,Clifford J. SteerIncludes supplementary material: 作者: llibretto 時間: 2025-3-25 03:57 作者: 烤架 時間: 2025-3-25 07:36
Introduction,athophysiology, and current diagnostic options for HCC. We will also cover molecular mechanisms, animal models of research, and emerging novel therapeutic options such as microRNA and stem cell therapies.作者: 構(gòu)成 時間: 2025-3-25 13:25 作者: Between 時間: 2025-3-25 16:13 作者: Pandemic 時間: 2025-3-25 22:32
Etiology,Western countries. In addition to the risk factors, gender differences were also shown to have an impact on the development of the disease. Various published reports have demonstrated that females are less susceptible to HCC than males, and the reasons for this significant gender difference are still unknown.作者: 緯度 時間: 2025-3-26 03:08 作者: 實現(xiàn) 時間: 2025-3-26 06:24
Molecular Mechanisms of HCC,ular and ‘omic’-based approaches. More recently, atypical expression of a number of a microRNAs have been shown to result in HCC. While the expression of these miRNAs vary according to the risk factor involved, their aberrant expression causes the dysregulation of critical cellular mechanism promoting HCC.作者: DENT 時間: 2025-3-26 09:25 作者: Provenance 時間: 2025-3-26 12:56 作者: 外星人 時間: 2025-3-26 18:44
Book 2014cular mechanisms involved in the disease process. Recent research in HCC has led to significant progress in our understanding of the cellular processes and molecular mechanisms that occur during multi-stage events that lead to hepatocarcinogenesis. The emergence of micro RNAs and molecular targeted 作者: 試驗 時間: 2025-3-26 22:57 作者: 殺菌劑 時間: 2025-3-27 04:53 作者: 骯臟 時間: 2025-3-27 07:39
Rajagopal N. Aravalli,Clifford J. Steer, and examine how recently identified androgen-regulated genes are likely to contribute to the development and progression of prostate cancer. Recent studies that have attempted to unravel how these genes are deregulated in androgen depletion independent prostate cancer will be included.作者: anesthesia 時間: 2025-3-27 10:05
Rajagopal N. Aravalli,Clifford J. Steer, and examine how recently identified androgen-regulated genes are likely to contribute to the development and progression of prostate cancer. Recent studies that have attempted to unravel how these genes are deregulated in androgen depletion independent prostate cancer will be included.作者: 鉗子 時間: 2025-3-27 15:42
Rajagopal N. Aravalli,Clifford J. Steer, and examine how recently identified androgen-regulated genes are likely to contribute to the development and progression of prostate cancer. Recent studies that have attempted to unravel how these genes are deregulated in androgen depletion independent prostate cancer will be included.作者: 發(fā)怨言 時間: 2025-3-27 19:57
, and examine how recently identified androgen-regulated genes are likely to contribute to the development and progression of prostate cancer. Recent studies that have attempted to unravel how these genes are deregulated in androgen depletion independent prostate cancer will be included.作者: Gum-Disease 時間: 2025-3-28 01:54 作者: Virtues 時間: 2025-3-28 04:21
Novel Therapeutic Strategies to Combat HCC,wth factor receptors and other signaling pathways, which are currently undergoing clinical trials. In addition, owing to the success of miR-26a, different miRNAs are also being tested in clinical trials to treat HCC. Stem cell therapy is also being developed as a HCC therapy.作者: 小溪 時間: 2025-3-28 07:33
2194-1173 o-RNA based therapies and personalized medicine to treat liver cancer. This book will be of interest to basic and clinical researchers, as well as to drug developers..978-3-319-09413-7978-3-319-09414-4Series ISSN 2194-1173 Series E-ISSN 2194-1181 作者: 文藝 時間: 2025-3-28 14:20
Rajagopal N. Aravalli,Clifford J. Steer the development and progression of prostate cancer. Recent studies that have attempted to unravel how these genes are deregulated in androgen depletion independent prostate cancer will be included.978-1-4419-2404-9978-0-387-69179-4作者: instill 時間: 2025-3-28 15:16
